Raymond James Financial (RJF) Earnings Analysis

Raymond James Financial (RJF) reported results in line with expectations in FY2026 on revenue of $62.0B versus the $62.9B estimate (+17.4% YoY) and EPS of $3.52. Below is the full Raymond James Financial earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Raymond James Financial (RJF) Earnings Analysis — key stats

Next earnings dateFeb 4, 2025
Latest reported quarterFY2026
Earnings verdictIn line
Revenue$62.0B (vs $62.9B est · -1.4% surprise · +17.4% YoY)
EPS$3.52 (vs $3.53 est · -0.3% surprise · -0.3% YoY)
Share price$490.50 (+1.0%)
Market cap$1.60T

What you'll find

Frequently asked questions

When is Raymond James Financial's next earnings date?
Raymond James Financial's (RJF) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Raymond James Financial (RJF) beat or miss earnings?
In FY2026, Raymond James Financial (RJF) posted in-line results — revenue of $62.0B versus the $62.9B estimate (-1.4% surprise) and EPS of $3.52 versus $3.53 expected (-0.3% surprise). Magnisto decodes every Raymond James Financial (RJF) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Raymond James Financial (RJF) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Raymond James Financial (RJF), anchored to the current $490.50 share price, so you can weigh the bull, base and bear cases for Raymond James Financial side by side.
Is Raymond James Financial (RJF) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Raymond James Financial fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.